2013
DOI: 10.1016/j.jcyt.2013.03.015
|View full text |Cite
|
Sign up to set email alerts
|

Age-dependent decrease in the chondrogenic potential of human bone marrow mesenchymal stromal cells expanded with fibroblast growth factor-2

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
40
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 49 publications
(42 citation statements)
references
References 37 publications
2
40
0
Order By: Relevance
“…25 Zaim et al 26 found that the adipogenic, osteogenic, and neurogenic differentiation potentials of hBMSCs declined with age, but that the chondrogenic potential did not. In contrast, Kanawa et al 27 reported that the adipogenic and osteogenic differentiation capacities of human BMSCs were unaffected by age, but the chondrogenic capacity of BMSCs declined with age. We used 3 volunteers as sources of BMSCs in the present study with an average age of 26 years.…”
Section: Discussionmentioning
confidence: 90%
“…25 Zaim et al 26 found that the adipogenic, osteogenic, and neurogenic differentiation potentials of hBMSCs declined with age, but that the chondrogenic potential did not. In contrast, Kanawa et al 27 reported that the adipogenic and osteogenic differentiation capacities of human BMSCs were unaffected by age, but the chondrogenic capacity of BMSCs declined with age. We used 3 volunteers as sources of BMSCs in the present study with an average age of 26 years.…”
Section: Discussionmentioning
confidence: 90%
“…47 Increased age has also been shown to reduce the chondrogenic potential of human MSCs. 48 Recent studies have shown that allogeneic MSCs can be used in humans without increased complication rates, and some companies have marketed allogeneic juvenile chondrocytes for cartilage repair (DeNovo Ò ; Zimmer, Inc.). The ultimate application of this technology may involve the use of allogeneic MSCs.…”
Section: Discussionmentioning
confidence: 99%
“…24 Kanawa and colleagues, however, reported that the adipogenic and osteogenic differentiation capacities of human BMSCs were unchanged by age, but that BMSCs' chondrogenic capacity declined. 34 As has been reviewed elsewhere, 35 molecular differences between young and aged MSCs likely partially account for the phenotypic differences between youthful and aged stem cells. Approximately 8000 genes were differentially expressed between murine (C57BL/6 WT) BMSCs from 2-, 8-, and 26-month-old sources.…”
Section: Donor Age Dependent Cell Senescencementioning
confidence: 99%